BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15578620)

  • 1. Carbimazole embryopathy: an emerging phenotype.
    Foulds N; Walpole I; Elmslie F; Mansour S
    Am J Med Genet A; 2005 Jan; 132A(2):130-5. PubMed ID: 15578620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antenatal carbimazole and choanal atresia: a new embryopathy.
    Wolf D; Foulds N; Daya H
    Arch Otolaryngol Head Neck Surg; 2006 Sep; 132(9):1009-11. PubMed ID: 16982979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choanal atresia associated with tracheoesophageal fistula: the spectrum of carbimazole embryopathy.
    Douchement D; Rakza T; Holder M; Bonne NX; Fayoux P
    Pediatrics; 2011 Sep; 128(3):e703-6. PubMed ID: 21807695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new possible phenotype of carbimazole embryopathy: A case report].
    Mellerio H; Gay CL; Forest MG; Orgiazzi J; Nicolino M
    Arch Pediatr; 2010 May; 17(5):511-6. PubMed ID: 20395117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hyperthyroidism in pregnancy and birth defects.
    Clementi M; Di Gianantonio E; Cassina M; Leoncini E; Botto LD; Mastroiacovo P;
    J Clin Endocrinol Metab; 2010 Nov; 95(11):E337-41. PubMed ID: 20668039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbimazole embryopathy-bilateral choanal atresia and patent vitello-intestinal duct: a case report and review of literature.
    Kannan L; Mishra S; Agarwal R; Kartikeyan V; Gupta N; Kabra M
    Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):649-51. PubMed ID: 18671255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choanal atresia: the result of maternal thyrotoxicosis or fetal carbimazole?
    Barwell J; Fox GF; Round J; Berg J
    Am J Med Genet; 2002 Jul; 111(1):55-6; discussion 54. PubMed ID: 12124735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Teratogenicity of carbimazole].
    Velin P; Dupont D; Golkar A
    Arch Pediatr; 1998 Nov; 5(11):1289. PubMed ID: 9853073
    [No Abstract]   [Full Text] [Related]  

  • 9. Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy.
    Bowman P; Osborne NJ; Sturley R; Vaidya B
    QJM; 2012 Feb; 105(2):189-93. PubMed ID: 21258054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Birth defects observed with maternal carbimazole treatment: Six cases reported to Nice's Pharmacovigilance Center.
    Koenig D; Spreux A; Hiéronimus S; Chichmanian RM; Bastiani F; Fénichel P; Brucker-Davis F
    Ann Endocrinol (Paris); 2010 Dec; 71(6):535-42. PubMed ID: 20934171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbimazole/methimazole embryopathy in siblings: a possible genetic susceptibility.
    Goel H; Dudding T
    Birth Defects Res A Clin Mol Teratol; 2013 Nov; 97(11):755-8. PubMed ID: 24265129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbimazole: cases of birth defects.
    Prescrire Int; 2010 Feb; 19(105):29. PubMed ID: 20458785
    [No Abstract]   [Full Text] [Related]  

  • 13. Choanal atresia - a recurrent feature of foetal carbimazole syndrome.
    Myers AK; Reardon W
    Clin Otolaryngol; 2005 Aug; 30(4):375-7. PubMed ID: 16209687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aplasia cutis after exposure to carbimazole in utero].
    Dutertre JP; Jonville AP; Moraine C; Autret E
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(4):575-6. PubMed ID: 1885895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aplasia cutis congenita and antithyroid drugs.
    Izhar R; Ghani T
    J Pak Med Assoc; 2002 Nov; 52(11):526-8. PubMed ID: 12585373
    [No Abstract]   [Full Text] [Related]  

  • 16. Carbimazole embryopathy.
    El Guendouz F; Hammoune N; Hommadi A; Zerhouni H; Baizri H
    Ann Endocrinol (Paris); 2017 Oct; 78(5):478-480. PubMed ID: 28870708
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacologic treatment of hyperthyroidism during pregnancy.
    Cassina M; Donà M; Di Gianantonio E; Clementi M
    Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):612-9. PubMed ID: 22511519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.
    Andersen SL; Olsen J; Wu CS; Laurberg P
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4373-81. PubMed ID: 24151287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leucopenia and atrial fibrillation: rare presentations of thyrotoxicosis in the first trimester.
    Oliver R; Nama VV; Howard RJ; Nikookam KH
    J Obstet Gynaecol; 2007 Jul; 27(5):521-3. PubMed ID: 17701808
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety of antithyroid drugs in pregnancy: update and therapy implications.
    Francis T; Francis N; Lazarus JH; Okosieme OE
    Expert Opin Drug Saf; 2020 May; 19(5):565-576. PubMed ID: 32223355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.